基本信息
浏览量:1
职业迁徙
个人简介
Her research project (ESTREA: Exome Sequencing in stages of Treatment REsistance to Antidepressants) aims to study the contribution of rare and common genetic variants to the risk of developing treatment-resistant depression. The innovative features of this project are the study of rare variants obtained through whole exome sequencing in antidepressant response and the availability of data on the number and type of failed antidepressant treatments in each participant.
Before working at King’s College London, Chiara Fabbri graduated in medicine and surgery at Bologna University (Italy), where she also completed her clinical training in psychiatry and she started her research activity. Since she was a medical student, pharmacogenetics has been her main research interest, but she also contributed to the study of the clinical factors involved in the modulation of pharmacological treatment response in psychiatric disorders.
Chiara Fabbri obtained her PhD degree at Maastricht University, Department of Psychiatry and Neuropsychology (The Netherlands), with the thesis entitled: Pharmacogenomics of antidepressant drugs: perspectives for the personalization of treatment in depression.
Research interests:
Pharmacogenomics
Clinical-demographic modulators of response to psychotropic medications
Personalized treatment of psychiatric disorders
Genetics of mood disorders
Before working at King’s College London, Chiara Fabbri graduated in medicine and surgery at Bologna University (Italy), where she also completed her clinical training in psychiatry and she started her research activity. Since she was a medical student, pharmacogenetics has been her main research interest, but she also contributed to the study of the clinical factors involved in the modulation of pharmacological treatment response in psychiatric disorders.
Chiara Fabbri obtained her PhD degree at Maastricht University, Department of Psychiatry and Neuropsychology (The Netherlands), with the thesis entitled: Pharmacogenomics of antidepressant drugs: perspectives for the personalization of treatment in depression.
Research interests:
Pharmacogenomics
Clinical-demographic modulators of response to psychotropic medications
Personalized treatment of psychiatric disorders
Genetics of mood disorders
研究兴趣
论文共 258 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Progress in neuro-psychopharmacology & biological psychiatry (2024): 110972-110972
Nature geneticspp.1-17, (2024)
medRxiv : the preprint server for health sciences (2024)
Lucie Bartova,Gernot Fugger,Markus Dold,Alexander Kautzky, Isabella Bairhuber, Philipp Kloimstein,Giuseppe Fanelli,Raffaella Zanardi,Ana Weidenauer,Dan Rujescu,Daniel Souery,Julien Mendlewicz,
Neuroscience Appliedpp.104059, (2024)
medRxiv : the preprint server for health sciences (2023)
引用0浏览0WOS引用
0
0
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2023): S92-S92
Federica Colombo,Federico Calesella,Beatrice Bravi, Lidia Fortaner-Uyà, Camilla Monopoli,Emma Tassi,Matteo Carminati,Raffaella Zanardi,Irene Bollettini,Sara Poletti,Paolo Brambilla,Alessandro Serretti,
medRxiv (Cold Spring Harbor Laboratory) (2023)
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn